The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Up 290.5% in November

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 41,000 shares, a growth of 290.5% from the October 31st total of 10,500 shares. Based on an average daily trading volume, of 26,100 shares, the short-interest ratio is currently 1.6 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Up 0.6 %

Shares of NASDAQ CGABL traded up $0.11 during mid-day trading on Wednesday, reaching $19.25. The company had a trading volume of 8,935 shares, compared to its average volume of 22,087. The firm has a 50 day simple moving average of $19.83 and a two-hundred day simple moving average of $19.04. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 52-week low of $17.49 and a 52-week high of $20.85.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, November 15th. Investors of record on Saturday, November 1st will be given a $0.2891 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 6.01%. The ex-dividend date is Friday, October 31st.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.